18F-FDG PET/CT在伪装为腹膜后软组织肉瘤的骨巨细胞瘤中的应用
本文报告一例36岁女性骨巨细胞瘤病例,最初被误诊为脊柱结核并接受抗结核治疗,影像学检查发现累及L2椎体的腹膜后巨大肿块,怀疑恶性软组织肿瘤,18F-FDG PET/CT提示腹膜后代谢活跃病灶,强调需组织病理学确诊。
要点
- 骨巨细胞瘤可发生于中轴骨,影像表现多样,易误诊为软组织或腹膜后肿块。
- 本例36岁女性最初被误诊为脊柱结核并开始抗结核治疗。
- 18F-FDG PET/CT提示腹膜后代谢活跃病灶,支持组织病理学确认的必要性。
核心结论
- 骨巨细胞瘤因影像表现多样且位置不典型,可被误诊为软组织或腹膜后肿块,导致诊断延迟和不恰当治疗。
研究设计与样本
- 病例报告:一例36岁女性,最初被误诊为脊柱结核并开始抗结核治疗。
主要发现
- 初始超声、CT和MRI显示累及L2椎体的腹膜后巨大肿块,怀疑恶性软组织肿瘤。
- 进一步18F-FDG PET/CT提示腹膜后代谢活跃病灶,强化了组织病理学确认的必要性。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Giant cell tumor of bone (GCTB) is a rare, benign but locally aggressive neoplasm that typically arises in the epiphysis of long bones. GCTB occurrence in the axial skeleton is less common. Due to its variable radiological appearance and unusual location, GCTB can be misdiagnosed as a soft tissue or retroperitoneal mass, leading to delays in diagnosis and inappropriate treatment. We present the case of a 36-year-old woman who was misdiagnosed as a case of spinal tuberculosis and was started on ATT. Initial imaging, including ultrasound, computed tomography (CT), and magnetic resonance imaging (MRI), revealed a large, retroperitoneal mass involving the L2 vertebral body, raising suspicion of a malignant soft tissue tumor. Further evaluation with 18 F-FDG PET/CT suggested a retroperitoneal metabolically active lesion, reinforcing the need for histopathological confirmation.
引用
- Dharmashaktu Y, Shamim SA, Rastogi S, et al. 18 F-FDG PET/CT in a Giant Cell Tumor of Bone Masquerading as a Retroperitoneal Soft Tissue Sarcoma. Clin Nucl Med. 2025. PMID: 40392137. doi:10.1097/RLU.0000000000005981
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。